{"disease":{"id":"thymoma-type-b3","name":"thymoma type b3"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04710628","title":"Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":43,"lead_sponsor_name":"MedSIR","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}